europabio-logoeuropabio-logoeuropabio-logoeuropabio-logo
  • About us
    • Who we are
      • Governance
      • Staff
      • Vacancies
    • What we do
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Cell & Gene Therapies
      • Medicines For Rare Diseases And Children
      • Regulatory Efficiency
      • Biosimilars & Public Procurement
      • Data & Digital
      • Patient Bio-Forum
    • Industrial Biotechnology Council
      • Food, Feed & Nutrition
      • Circular Bioeconomy
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
  • Activities
    • 25 Years of Innovation
    • EFIB 2022
    • European Biotech Week
  • Events
  • Newsroom
    • News & Publications
    • Newsletter
    • Library
Become a member
✕

EuropaBio Members nominate Europe’s biotechnology landmarks from the last 25 years

03/07/2021
PRESS RELEASE

Brussels, 5 July 2021

From micro-organism production of the world’s vitamin B2, a revolution in cancer therapy using our own immune systems, and the first Covid mRNA vaccine approved – these are just a few examples of the selected landmarks in biotechnology that were officially announced today as the start of EuropaBio’s 25th Anniversary programme.

To mark a quarter century of impactful biotechnology since EuropaBio launch, members have been nominating important scientific, industry and ecosystem developments that shape our lives now. Today sees publication of almost 30 nominations in the first wave received from Members, with over 50 anticipated by the end of anniversary celebrations in 2021. They recognise brilliant science, innovative companies beakthroughs and a European landscape that enabled new medicines and novel materials.

‘I am thrilled that we received so many excellent nominations from Members, and these show us that biotechnology impacts so many aspects of our lives.. Behind every headline product, are decades of scientific advance from researchers and innovators in the public and private sector. They are, in turn, enabled by the collaborative landscape that Europe has built across borders to amplify strengths and grow together. Our 25th anniversary is a great opportunity not only to celebrate these achievements but also to gather the community and look ahead to the next 25 years.’, says Dr Claire Skentelbery, Director General of EuropaBio.

The anniversary nominations will be amplified through webinars, interviews, conversations on social media discussing some of the key drivers that made them a reality. The year will end with a gala evening in Brussels recognising the best healthcare and industrial biotechnology advances from the anniversary. The ceremony will be followed by a presentation of the 2021 SME Award from EuropaBio, looking to the next generation of landmark biotechnology innovation.

Visit the dedicated anniversary website at www.europabio25.org and follow EuropaBio anniversary celebrations through our weekly newsletter.

EuropaBio Members nominate Europe’s biotechnology landmarks from the last 25 years


Download
Share
Alexandra Simionca
Alexandra Simionca

Related posts

23/03/2023

Unlocking the Potential of Biotechnology Innovation for Patients


Read more
16/03/2023

Vision, clarity and enabling – the drivers for Europe’s biomanufacturing future


Read more
07/03/2023

Disc Medicine joins EuropaBio: life-changing medicines for patients with hematologic disorders


Read more
06/03/2023

Can the Pharmaceutical Strategy Deliver for Europe?


Read more

Important links

  • Unlocking the Potential of Biotechnology Innovation for Patients
  • Vision, clarity and enabling – the drivers for Europe’s biomanufacturing future

Categories in our Newsroom

Subscribe for our newsletter

Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


Subscribe
EuropaBio-Logo-White

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 2600 biotech companies, 2300 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2023 Europabio. All Rights Reserved. Designed by EYAS
Become a member
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkLegal & Cookies